Global Cancer Biomarker Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Report ID: GIR2112240128 | Category: Medical Devices & Consumables | Pages: 115 | Format: PDF | Published Date: April 01,2022

Request Sample Enquiry before buying Ask For Discount

Single User-$3480.00 Multi User-$5220.00

Report Description
View Table of Contents

Report Summary

The Cancer Biomarker market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Cancer Biomarker market size is estimated to be worth US$ 20140 million in 2021 and is forecast to a readjusted size of USD 41530 million by 2028 with a CAGR of 10.9% during review period. Diagnostics accounting for % of the Cancer Biomarker global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Protein Biomarker segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Cancer Biomarker include Thermo Fisher Scientific, Bio-Rad Laboratories, Roche Diagnostics, Qiagen, and Illumina, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Cancer Biomarker market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
    Protein Biomarker
    Genetic Biomarker
Market segment by Application can be divided into
    Diagnostics
    Research
    Others
The key market players for global Cancer Biomarker market are listed below:
    Thermo Fisher Scientific
    Bio-Rad Laboratories
    Roche Diagnostics
    Qiagen
    Illumina
    GE Healthcare
    Agilent Technologies
    Biomérieux SA
    Merck & Co.
    Abbott Laboratories
    Becton, Dickinson and Company
    Danaher Corporation
    Myriad Genetics
    Sysmex Corporation
    Hologic
    Quest Diagnostics
Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Cancer Biomarker product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Cancer Biomarker, with price, sales, revenue and global market share of Cancer Biomarker from 2019 to 2022.
Chapter 3, the Cancer Biomarker competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Cancer Biomarker breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Cancer Biomarker market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Cancer Biomarker.
Chapter 13, 14, and 15, to describe Cancer Biomarker sales channel, distributors, customers, research findings and conclusion, appendix and data source.

1 Market Overview
    1.1 Cancer Biomarker Introduction
    1.2 Market Analysis by Type
        1.2.1 Overview: Global Cancer Biomarker Revenue by Type: 2017 Versus 2021 Versus 2028
        1.2.2 Protein Biomarker
        1.2.3 Genetic Biomarker
    1.3 Market Analysis by Application
        1.3.1 Overview: Global Cancer Biomarker Revenue by Application: 2017 Versus 2021 Versus 2028
        1.3.2 Diagnostics
        1.3.3 Research
        1.3.4 Others
    1.4 Global Cancer Biomarker Market Size & Forecast
        1.4.1 Global Cancer Biomarker Sales in Value (2017 & 2021 & 2028)
        1.4.2 Global Cancer Biomarker Sales in Volume (2017-2028)
        1.4.3 Global Cancer Biomarker Price (2017-2028) 
    1.5 Global Cancer Biomarker Production Capacity Analysis
        1.5.1 Global Cancer Biomarker Total Production Capacity (2017-2028)
        1.5.2 Global Cancer Biomarker Production Capacity by Geographic Region
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Cancer Biomarker Market Drivers
        1.6.2 Cancer Biomarker Market Restraints
        1.6.3 Cancer Biomarker Trends Analysis
2 Manufacturers Profiles
    2.1 Thermo Fisher Scientific
        2.1.1 Thermo Fisher Scientific Details
        2.1.2 Thermo Fisher Scientific Major Business
        2.1.3 Thermo Fisher Scientific Cancer Biomarker Product and Services
        2.1.4 Thermo Fisher Scientific Cancer Biomarker Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.2 Bio-Rad Laboratories
        2.2.1 Bio-Rad Laboratories Details
        2.2.2 Bio-Rad Laboratories Major Business
        2.2.3 Bio-Rad Laboratories Cancer Biomarker Product and Services
        2.2.4 Bio-Rad Laboratories Cancer Biomarker Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.3 Roche Diagnostics
        2.3.1 Roche Diagnostics Details
        2.3.2 Roche Diagnostics Major Business
        2.3.3 Roche Diagnostics Cancer Biomarker Product and Services
        2.3.4 Roche Diagnostics Cancer Biomarker Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.4 Qiagen
        2.4.1 Qiagen Details
        2.4.2 Qiagen Major Business
        2.4.3 Qiagen Cancer Biomarker Product and Services
        2.4.4 Qiagen Cancer Biomarker Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.5 Illumina
        2.5.1 Illumina Details
        2.5.2 Illumina Major Business
        2.5.3 Illumina Cancer Biomarker Product and Services
        2.5.4 Illumina Cancer Biomarker Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.6 GE Healthcare
        2.6.1 GE Healthcare Details
        2.6.2 GE Healthcare Major Business
        2.6.3 GE Healthcare Cancer Biomarker Product and Services
        2.6.4 GE Healthcare Cancer Biomarker Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.7 Agilent Technologies
        2.7.1 Agilent Technologies Details
        2.7.2 Agilent Technologies Major Business
        2.7.3 Agilent Technologies Cancer Biomarker Product and Services
        2.7.4 Agilent Technologies Cancer Biomarker Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.8 Biomérieux SA
        2.8.1 Biomérieux SA Details
        2.8.2 Biomérieux SA Major Business
        2.8.3 Biomérieux SA Cancer Biomarker Product and Services
        2.8.4 Biomérieux SA Cancer Biomarker Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.9 Merck & Co.
        2.9.1 Merck & Co. Details
        2.9.2 Merck & Co. Major Business
        2.9.3 Merck & Co. Cancer Biomarker Product and Services
        2.9.4 Merck & Co. Cancer Biomarker Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.10 Abbott Laboratories
        2.10.1 Abbott Laboratories Details
        2.10.2 Abbott Laboratories Major Business
        2.10.3 Abbott Laboratories Cancer Biomarker Product and Services
        2.10.4 Abbott Laboratories Cancer Biomarker Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.11 Becton, Dickinson and Company
        2.11.1 Becton, Dickinson and Company Details
        2.11.2 Becton, Dickinson and Company Major Business
        2.11.3 Becton, Dickinson and Company Cancer Biomarker Product and Services
        2.11.4 Becton, Dickinson and Company Cancer Biomarker Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.12 Danaher Corporation
        2.12.1 Danaher Corporation Details
        2.12.2 Danaher Corporation Major Business
        2.12.3 Danaher Corporation Cancer Biomarker Product and Services
        2.12.4 Danaher Corporation Cancer Biomarker Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.13 Myriad Genetics
        2.13.1 Myriad Genetics Details
        2.13.2 Myriad Genetics Major Business
        2.13.3 Myriad Genetics Cancer Biomarker Product and Services
        2.13.4 Myriad Genetics Cancer Biomarker Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.14 Sysmex Corporation
        2.14.1 Sysmex Corporation Details
        2.14.2 Sysmex Corporation Major Business
        2.14.3 Sysmex Corporation Cancer Biomarker Product and Services
        2.14.4 Sysmex Corporation Cancer Biomarker Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.15 Hologic
        2.15.1 Hologic Details
        2.15.2 Hologic Major Business
        2.15.3 Hologic Cancer Biomarker Product and Services
        2.15.4 Hologic Cancer Biomarker Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.16 Quest Diagnostics
        2.16.1 Quest Diagnostics Details
        2.16.2 Quest Diagnostics Major Business
        2.16.3 Quest Diagnostics Cancer Biomarker Product and Services
        2.16.4 Quest Diagnostics Cancer Biomarker Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Cancer Biomarker Breakdown Data by Manufacturer
    3.1 Global Cancer Biomarker Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
    3.2 Global Cancer Biomarker Revenue by Manufacturer (2019, 2020, 2021, and 2022)
    3.3 Key Manufacturer Market Position in Cancer Biomarker
    3.4 Market Concentration Rate
        3.4.1 Top 3 Cancer Biomarker Manufacturer Market Share in 2021
        3.4.2 Top 6 Cancer Biomarker Manufacturer Market Share in 2021
    3.5 Global Cancer Biomarker Production Capacity by Company: 2021 VS 2022
    3.6 Manufacturer by Geography: Head Office and Cancer Biomarker Production Site
    3.7 New Entrant and Capacity Expansion Plans
    3.8 Mergers & Acquisitions
4 Market Analysis by Region
    4.1 Global Cancer Biomarker Market Size by Region
        4.1.1 Global Cancer Biomarker Sales in Volume by Region (2017-2028)
        4.1.2 Global Cancer Biomarker Revenue by Region (2017-2028)
    4.2 North America Cancer Biomarker Revenue (2017-2028)
    4.3 Europe Cancer Biomarker Revenue (2017-2028)
    4.4 Asia-Pacific Cancer Biomarker Revenue (2017-2028)
    4.5 South America Cancer Biomarker Revenue (2017-2028)
    4.6 Middle East and Africa Cancer Biomarker Revenue (2017-2028)
5 Market Segment by Type
    5.1 Global Cancer Biomarker Sales in Volume by Type (2017-2028)
    5.2 Global Cancer Biomarker Revenue by Type (2017-2028)
    5.3 Global Cancer Biomarker Price by Type (2017-2028)
6 Market Segment by Application
    6.1 Global Cancer Biomarker Sales in Volume by Application (2017-2028)
    6.2 Global Cancer Biomarker Revenue by Application (2017-2028)
    6.3 Global Cancer Biomarker Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
    7.1 North America Cancer Biomarker Sales by Type (2017-2028)
    7.2 North America Cancer Biomarker Sales by Application (2017-2028)
    7.3 North America Cancer Biomarker Market Size by Country
        7.3.1 North America Cancer Biomarker Sales in Volume by Country (2017-2028)
        7.3.2 North America Cancer Biomarker Revenue by Country (2017-2028)
        7.3.3 United States Market Size and Forecast (2017-2028)
        7.3.4 Canada Market Size and Forecast (2017-2028)
        7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
    8.1 Europe Cancer Biomarker Sales by Type (2017-2028)
    8.2 Europe Cancer Biomarker Sales by Application (2017-2028)
    8.3 Europe Cancer Biomarker Market Size by Country
        8.3.1 Europe Cancer Biomarker Sales in Volume by Country (2017-2028)
        8.3.2 Europe Cancer Biomarker Revenue by Country (2017-2028)
        8.3.3 Germany Market Size and Forecast (2017-2028)
        8.3.4 France Market Size and Forecast (2017-2028)
        8.3.5 United Kingdom Market Size and Forecast (2017-2028)
        8.3.6 Russia Market Size and Forecast (2017-2028)
        8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
    9.1 Asia-Pacific Cancer Biomarker Sales by Type (2017-2028)
    9.2 Asia-Pacific Cancer Biomarker Sales by Application (2017-2028)
    9.3 Asia-Pacific Cancer Biomarker Market Size by Region
        9.3.1 Asia-Pacific Cancer Biomarker Sales in Volume by Region (2017-2028)
        9.3.2 Asia-Pacific Cancer Biomarker Revenue by Region (2017-2028)
        9.3.3 China Market Size and Forecast (2017-2028)
        9.3.4 Japan Market Size and Forecast (2017-2028)
        9.3.5 Korea Market Size and Forecast (2017-2028)
        9.3.6 India Market Size and Forecast (2017-2028)
        9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
        9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
    10.1 South America Cancer Biomarker Sales by Type (2017-2028)
    10.2 South America Cancer Biomarker Sales by Application (2017-2028)
    10.3 South America Cancer Biomarker Market Size by Country
        10.3.1 South America Cancer Biomarker Sales in Volume by Country (2017-2028)
        10.3.2 South America Cancer Biomarker Revenue by Country (2017-2028)
        10.3.3 Brazil Market Size and Forecast (2017-2028)
        10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
    11.1 Middle East & Africa Cancer Biomarker Sales by Type (2017-2028)
    11.2 Middle East & Africa Cancer Biomarker Sales by Application (2017-2028)
    11.3 Middle East & Africa Cancer Biomarker Market Size by Country
        11.3.1 Middle East & Africa Cancer Biomarker Sales in Volume by Country (2017-2028)
        11.3.2 Middle East & Africa Cancer Biomarker Revenue by Country (2017-2028)
        11.3.3 Turkey Market Size and Forecast (2017-2028)
        11.3.4 Egypt Market Size and Forecast (2017-2028)
        11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
        11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
    12.1 Raw Material of Cancer Biomarker and Key Manufacturers
    12.2 Manufacturing Costs Percentage of Cancer Biomarker
    12.3 Cancer Biomarker Production Process
    12.4 Cancer Biomarker Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
    13.1 Sales Channel
        13.1.1 Direct Marketing
        13.1.2 Indirect Marketing
    13.2 Cancer Biomarker Typical Distributors
    13.3 Cancer Biomarker Typical Customers
14 Research Findings and Conclusion
15 Appendix
    15.1 Methodology
    15.2 Research Process and Data Source
    15.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Global Cancer Biomarker Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?